WIRED purchased four peptide products—PT-141, BPC-157, NAD+, and retatrutide—from a Brooklyn bodega for $376.20 and sent them to Finnrick, an Austin testing startup, for independent analysis. Results showed the vials had low levels of heavy metals and endotoxins but none of the active ingredients listed on their labels, meaning the products were either mislabeled or degraded beyond recognition.
Verge senior reviewer Victoria Song describes a growing online subculture of men sharing 'looksmaxxing' routines, including testosterone boosters, gray-market peptides, and drugs like Cialis taken off-label for longevity rather than their approved use. Figures like biohacker Bryan Johnson promote these regimens publicly, framing them as tools for physical optimization, appearance, or anti-aging rather than treating any diagnosed condition.
RonanRX, a Y Combinator S26 startup, has launched a service offering personalized, compounded GLP-1 medications tied to individual patient prescriptions rather than mass-produced doses. The company emphasizes a doctor-led, pharmacist-verified process for each preparation, with ongoing physician support throughout treatment.
A report examines the booming gray market for injectable peptide drugs, showing how sellers like Qingdao Sigma build slick, professional-looking websites using AI coding tools. These sites feature fake TrustPilot-style review pages filled with AI-generated testimonials, despite the companies having no actual presence on TrustPilot itself.